Tools
Cell Liquefactive Necrosis
Introduction
Cells maintain their structure and function by adapting to environmental changes.[1] However, when subjected to severe stress, exposure to harmful agents, or intrinsic defects, cells may reach a threshold where adaptation is no longer possible, leading to cell injury.[2] This process involves various cellular and metabolic disruptions and can follow a trajectory from reversible injury to irreversible damage and cell death.[3]
Reversible Cell Injury
In the early or mild stages of injury, cellular damage remains reversible if the stressor is removed. Although there may be noticeable structural and functional impairments during this phase, the cell retains the capacity to recover and restore normal function. This stage is characterized by alterations in metabolic pathways and organelles without permanent loss of cell viability.[4] If the harmful stimulus persists, the damage may progress beyond the point of repair, resulting in irreversible injury and ultimately cell death. These stages are central to understanding the cellular responses to various pathological conditions.[5]
Cell Necrosis
Irreversible injury to cells due to encounters with noxious stimuli invariably leads to cell death. Such noxious stimuli include infectious agents (bacteria, viruses, fungi, parasites), oxygen deprivation or hypoxia, and extreme environmental conditions such as heat, radiation, or exposure to ultraviolet irradiation. The resulting death is known as necrosis, a term usually distinguished from the other major consequences of irreversible injury, known as cell death by apoptosis.[6] Apoptosis is a programmed or organized cell death that could be physiological or pathological. Additional information regarding this form of cell death is outside this chapter's scope. Necrosis, a cell death, is almost always associated with a pathological process.[7]
When cells die by necrosis, they exhibit 2 major types of microscopes or macroscopic appearance. The first is liquefactive necrosis, also known as colliquative necrosis, which is characterized by partial or complete dissolution of dead tissue and transformation into a liquid, viscous mass. The loss of tissue and cellular profile occurs within hours in liquefactive necrosis. In contrast to liquefactive necrosis, coagulative necrosis, the other major pattern, is characterized by maintaining normal architecture of necrotic tissue for several days after cell death.[8]
Liquefaction derives from the slimy, liquid-like nature of tissues undergoing liquefactive necrosis.[9] This morphological appearance is partly attributable to hydrolytic enzymes' activities, which cause the dissolution of cellular organelles in a necrosis cell. The enzymes responsible for liquefaction are derived from bacterial or lysosomal hydrolytic enzymes.[10][11]
Other types of Necrosis
In addition to liquefactive and coagulative necrosis, the other morphological patterns associated with cell death by necrosis are:
- Caseous Necrosis
- Fat Necrosis
- Gangrenous Necrosis
- Fibrinoid Necrosis
The other types of necrosis listed above do not represent distinct pathological entities. Rather, they are descriptive terms widely used to describe necrosis occurring in specific clinical scenarios or organ damage.
Coagulative Necrosis
This is the default pattern of necrosis associated with ischemia or hypoxia in every organ except the brain.[8][12]
- Gross Appearance: Tissue is firm, and architecture is maintained for days after cell death
- Microscopic: Preserved cell outlines without nuclei
Liquefactive Necrosis
The pattern of necrosis is seen with infections. Also, the pattern is seen following ischemic injury in the brain. While the reason for liquefactive necrosis following ischemic injury in the brain is poorly understood, the release of digestive enzymes and constituents of neutrophils is the reason for liquefaction in infections.[13][14]
- Gross Appearance: The tissue is liquid and sometimes creamy yellow because of pus formation
- Microscopic: Inflammatory cells with numerous neutrophils
Caseous Necrosis
A unique type of cell death is seen with tuberculosis.
- Gross Appearance: White, soft, cheesy-looking (caseating) material
- Microscopic: A uniformly eosinophilic center (necrosis) surrounded by a collar of lymphocytes and activated macrophages (giant cells, epithelioid cells)
- The entire structure formed in response to tuberculosis is known as a granuloma.[15]
Fat Necrosis
Fat necrosis occurs from acute inflammation affecting tissues with numerous adipocytes, such as pancreas and breast tissue. Damaged cells release digestive enzymes, which break down lipids to generate free fatty acids.[16]
- Gross Appearance: Whitish deposits as a result of the formation of calcium soaps
- Microscopic: Anucleated adipocytes with calcium deposits (seen on H&E as areas of bluish stains)
Fibrinoid Necrosis
This is a pattern associated with vascular damage (autoimmunity, immune-complex deposition, infections (viruses, spirochetes, rickettsiae).[17]
- Gross Appearance: Usually not grossly discernible
- Microscopic: Deposition of fibrin within blood vessels
Gangrenous Necrosis
Clinically, this describes ischemic necrosis of the lower limbs (sometimes upper limbs or digits).[18]
- Gross Appearance: Black skin with varying degrees of putrefaction
- Microscopic: Combination of coagulative necrosis due to ischemia (dry gangrene); and liquefactive necrosis (wet gangrene) if a bacterial infection is superimposed
These represent morphological patterns that are visible grossly and microscopically. Fibrinoid necrosis is usually visible only microscopically. In subsequent paragraphs, we discuss the gross and microscopic findings in liquefactive necrosis.
Etiology
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
The cause of cell death, the organ affected, and the duration of cell death determine patterns of necrosis (liquefactive or coagulative).[19] Liquefactive necrosis is a pattern of cell death caused by several etiological factors.
Major Causes of Liquefactive Necrosis
In all solid organs of the body:
- Infectious agents (bacteria, fungi, viruses, parasites)
In the brain
- Infectious agents
- Hypoxia/Ischemia (the occurrence of liquefaction as a pattern of necrosis in response to hypoxic injury in the brain is an exception to observed findings in the rest of the body
- Tissues in all other mammalian body systems usually undergo cell death by coagulative necrosis in response to hypoxia. The reason for this difference is poorly understood).[20]
Pathophysiology
Liquefactive Necrosis
Three major factors contribute to liquefactive necrosis:
- Enzymatic digestion of cellular debris in dead or dying tissues
- Enzymatic digestion of surrounding tissues
- Denaturation of cellular proteins
Because infectious agents are rich in digestive enzymes and likely to elicit an inflammatory response, they can rapidly increase cellular digestion. This manifests as liquefactive necrosis. Cellular dissolution and digestion are brought about by several enzymes, some from the infecting organism and some from the lysosome of the dying cells.[21]
Enzymes involved in liquefaction include:
- Proteases (collagenases, elastases)
- Deoxyribonuclease
- Lysosomal enzymes
Coagulative Necrosis
A major difference between liquefactive and coagulative necrosis is that in liquefactive necrosis, the enzyme system of the necrotic tissue is intact and can commence the process of cellular digestion almost immediately via autolysis. In addition to self-digestion (autolysis), heterolysis occurs due to a release of enzymes and inflammatory cells from the invading organism.[22] Cellular digestion is principally dependent on heterolysis in coagulative necrosis since a hypoxic injury would have damaged the enzymes of the cells undergoing ischemic necrosis. This partly explains the late onset of digestion and removal of dead tissues in this type of necrosis.[23]
Caseous Necrosis
This pattern is almost unique to tuberculosis. Certain fungi can also exhibit caseous necrosis. In tuberculosis, the organism is partially resistant to digestion and phagocytosis by tissue macrophages, leading to the activation of the macrophages to form giant cells and epithelioid cells. This sets off several steps that lead to the recruitment of more macrophages and inflammatory cells, the production of cytokines, and slow degradation of the mycobacteria. Mycolic acid and other lipid constituents of the mycobacteria cell wall confer a characteristic "cheese-like" appearance on the tubercle of tuberculosis, hence the descriptive term "caseous."[24]
Fat Necrosis
The release of lipases and amylases from the pancreatic cells is the major trigger for fat necrosis in the pancreas. This process is usually triggered by several factors leading to pancreas inflammation or pancreatitis.[25] Causes of acute pancreatitis include alcohol, gallbladder stones, poisoning, and insect bites. Since an inadvertent release of enzymes triggers fat necrosis in the pancreas, this process is also called enzymatic fat necrosis.[26] Breast tissues can also give rise to fat necrosis. The trigger for this is usually trauma.[27]
Fibrinoid Necrosis
This is a pattern that is not grossly discernible but can be seen microscopically. Fibrinoid necrosis is a pattern of cell death characterized by endothelial damage and exudation of plasma proteins (especially fibrin).[17]
Gangrenous Necrosis
See the description in the introduction above; this is not a true pathological type; rather, it is a clinical term describing coagulative necrosis (dry gangrene) or sometimes liquefactive necrosis (wet gangrene) affecting the extremities.
History and Physical
Clinical Examples of Necrosis
Infections
- Abscesses (brain, lungs, liver, skin)
- Lung infections
- Skin Infections
- Wet Gangrene
- Fournier gangrene
- Brain abscess
Hypoxic Injury
Evaluation
Appropriate history and physical examination findings would guide diagnosis and management, including which evaluation studies to order. Liquefactive necrosis closely mirrors acute inflammation and the response to an infectious process. The only exception is in the brain, where liquefaction may occur in response to ischemia.
Evaluation and management are geared toward effective clinical management, whether medical with either antibiotics or surgical management. Hypoxic injury is the cause of coagulative necrosis. The reestablishment of blood flow or oxygen supply is reperfusion; this is important for management. Hence, for this pattern of tissue damage, studies such as Doppler ultrasound are useful in determining blood flow.[30]
Useful Evaluation
- Physical examination: Monitor vital signs to evaluate overall health and identify any immediate complications.
- Laboratory investigations: Conduct tests such as complete blood count to check for infection or anemia, blood cultures to detect underlying infections, and urine culture and urinalysis to assess kidney function.
- Imaging studies: Use x-rays to rule out fractures or other bony injuries.
- Venous Doppler scan: Focus on venous blood flow, which is essential for detecting deep vein thrombosis.
- Computed tomography scans: These scans provide detailed images of internal structures, aiding in assessing organ damage.
- Serum electrolytes: Analyze electrolyte levels to manage metabolic imbalances commonly associated with hypoxic conditions.
Treatment / Management
Management of Infectious Processes
Antibiotics are the mainstay of managing infectious processes.[31] Clinical findings and antibiotic susceptibility would guide the choice of antibiotics.[6] Surgical management is also often indicated and includes:
- Drainage of abscesses
- Wound debridement
- Amputation
Management of Ischemic Processes/Stroke
- Myocardial infarction is the prototype example of coagulative necrosis, which requires urgent management. Early removal of the obstructive lesions in the coronary arteries is a crucial step in the management of myocardial infarction. This is usually achieved medically or by an invasive procedure.[29]
- Stroke management is a multidisciplinary, multispecialist effort that should consider several factors, including the extent of residual damage, the risk of reoccurrence, and the patient's rehabilitative needs.[32]
Management of Caseous Necrosis
This requires standard tuberculosis management, including combination antibiotics and close laboratory and clinical monitoring.[33](B3)
Management of Gangrenous Necrosis
This is a serious medical and surgical situation that requires antibiotics and sometimes necessitates the removal of dead tissues (debridement). In severe, life-threatening cases, an amputation may be necessary.[34](B3)
Differential Diagnosis
The differential diagnosis includes the following:
- Complex regional pain syndrome
- Inflammatory synovitis
- Osteoarthritis
- Osteomyelitis
- Soft tissue trauma (eg, Labral tear)
Prognosis
The prognosis for liquefactive necrosis is influenced by several key factors, including the underlying cause, the specific organ involved, the severity of tissue damage, and the patient's overall health. Infections leading to abscess formation generally have a better outcome with timely antibiotic therapy and drainage. At the same time, ischemic events, particularly in the brain, often result in permanent functional deficits and poorer recovery.
Localized necrosis typically heals through fibrosis, while more extensive tissue damage raises the risk of serious complications such as sepsis or multi-organ failure. Factors like age, existing health conditions, and immune system status also play a crucial role in determining recovery chances. Early diagnosis and effective management are essential for enhancing prognosis and improving recovery outcomes.[35]
Complications
Some complications can include the following:
- Abscess formation: This is common in infections and requires drainage or surgical intervention.
- Sepsis: This is a complication, particularly if caused by pyogenic organisms.
- Permanent dysfunction: In cases involving liquefactive necrosis, particularly in critical organs such as the brain or spinal cord, there can be lasting functional impairments that are often irreversible.[36]
- Cyst formation: In brain necrosis, areas may resolve into fluid-filled cysts.
Deterrence and Patient Education
Preventing liquefactive necrosis requires addressing underlying etiologies, such as infections and ischemia, through evidence-based measures. These include maintaining proper hygiene, managing chronic conditions such as diabetes and hypertension, adopting a healthy lifestyle, and ensuring timely administration of vaccines. Early recognition of clinical warning signs, including persistent fever, localized pain or swelling, or acute neurological deficits, is critical for initiating prompt medical intervention.
Adherence to prescribed therapeutic regimens, such as completing antibiotic courses, is essential to reduce complications. Furthermore, rehabilitation strategies and psychological support are integral in managing the long-term sequelae of necrosis. Empowering patients through education and fostering effective communication with healthcare providers are key strategies to mitigate risks and improve clinical outcomes.
Enhancing Healthcare Team Outcomes
Several types of necrotic processes occur following injury or infection. The pathologist makes the final diagnosis of the type of necrosis. Sometimes, patients may need to be referred to the surgeon or radiologist for aspiration or debridement of the necrotic tissues. Often, radical debridement is required in cases of Fournier gangrene, and the patient and family should be notified about the possibility of a stoma. If time permits, a stoma nurse should visit patients who are about to undergo an abdominal procedure for gangrene or necrosis.
References
Brooks AN, Turkarslan S, Beer KD, Lo FY, Baliga NS. Adaptation of cells to new environments. Wiley interdisciplinary reviews. Systems biology and medicine. 2011 Sep-Oct:3(5):544-61. doi: 10.1002/wsbm.136. Epub 2010 Dec 31 [PubMed PMID: 21197660]
Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. International journal of cell biology. 2010:2010():214074. doi: 10.1155/2010/214074. Epub 2010 Feb 21 [PubMed PMID: 20182529]
Trump BF, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicologic pathology. 1997 Jan-Feb:25(1):82-8 [PubMed PMID: 9061857]
Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open biology. 2020 Sep:10(9):200223. doi: 10.1098/rsob.200223. Epub 2020 Sep 30 [PubMed PMID: 32993416]
Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. International review of cell and molecular biology. 2012:298():229-317. doi: 10.1016/B978-0-12-394309-5.00006-7. Epub [PubMed PMID: 22878108]
Level 3 (low-level) evidenceD'Arcy MS. Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell biology international. 2019 Jun:43(6):582-592. doi: 10.1002/cbin.11137. Epub 2019 Apr 25 [PubMed PMID: 30958602]
Gudipaty SA, Conner CM, Rosenblatt J, Montell DJ. Unconventional Ways to Live and Die: Cell Death and Survival in Development, Homeostasis, and Disease. Annual review of cell and developmental biology. 2018 Oct 6:34():311-332. doi: 10.1146/annurev-cellbio-100616-060748. Epub 2018 Aug 8 [PubMed PMID: 30089222]
Tonnus W, Meyer C, Paliege A, Belavgeni A, von Mässenhausen A, Bornstein SR, Hugo C, Becker JU, Linkermann A. The pathological features of regulated necrosis. The Journal of pathology. 2019 Apr:247(5):697-707. doi: 10.1002/path.5248. Epub 2019 Feb 25 [PubMed PMID: 30714148]
Krishna M. Patterns of necrosis in liver disease. Clinical liver disease. 2017 Aug:10(2):53-56. doi: 10.1002/cld.653. Epub 2017 Aug 30 [PubMed PMID: 30992760]
Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT open reviews. 2019 Mar:4(3):85-97. doi: 10.1302/2058-5241.4.180036. Epub 2019 Mar 15 [PubMed PMID: 30993010]
Ye W, Shu H, Wen Y, Ye W, Li H, Qin Y, Chen L, Li X. Renal histopathology of prolonged acute kidney injury in HELLP syndrome: a case series and literature review. International urology and nephrology. 2019 Jun:51(6):987-994. doi: 10.1007/s11255-019-02135-z. Epub 2019 Apr 15 [PubMed PMID: 30989562]
Level 2 (mid-level) evidenceWang Z, Gao L, Wang W, Guo X, Feng C, Lian W, Li Y, Xing B. Coagulative necrotic pituitary adenoma apoplexy: A retrospective study of 21 cases from a large pituitary center in China. Pituitary. 2019 Feb:22(1):13-28. doi: 10.1007/s11102-018-0922-2. Epub [PubMed PMID: 30390276]
Level 2 (mid-level) evidenceZeng J, Liu Z, Shen G, Zhang Y, Li L, Wu Z, Luo D, Gu Q, Mao H, Wang L. MRI evaluation of pulmonary lesions and lung tissue changes induced by tuberculosis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2019 May:82():138-146. doi: 10.1016/j.ijid.2019.03.004. Epub 2019 Mar 12 [PubMed PMID: 30872041]
Chung AG, Frye JB, Zbesko JC, Constantopoulos E, Hayes M, Figueroa AG, Becktel DA, Antony Day W, Konhilas JP, McKay BS, Nguyen TV, Doyle KP. Liquefaction of the Brain following Stroke Shares a Similar Molecular and Morphological Profile with Atherosclerosis and Mediates Secondary Neurodegeneration in an Osteopontin-Dependent Mechanism. eNeuro. 2018 Sep-Oct:5(5):. doi: 10.1523/ENEURO.0076-18.2018. Epub 2018 Nov 8 [PubMed PMID: 30417081]
Fayyazi A, Eichmeyer B, Soruri A, Schweyer S, Herms J, Schwarz P, Radzun HJ. Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. The Journal of pathology. 2000 Aug:191(4):417-25 [PubMed PMID: 10918217]
Level 3 (low-level) evidenceMateu A, Ramudo L, Manso MA, Closa D, De Dios I. Acinar inflammatory response to lipid derivatives generated in necrotic fat during acute pancreatitis. Biochimica et biophysica acta. 2014 Sep:1842(9):1879-86. doi: 10.1016/j.bbadis.2014.06.016. Epub 2014 Jun 21 [PubMed PMID: 24959971]
Bajema IM, Bruijn JA. What stuff is this! A historical perspective on fibrinoid necrosis. The Journal of pathology. 2000 Jul:191(3):235-8 [PubMed PMID: 10878543]
Level 3 (low-level) evidenceButtolph A, Sapra A. Gangrene. StatPearls. 2024 Jan:(): [PubMed PMID: 32809387]
Walker NI, Harmon BV, Gobé GC, Kerr JF. Patterns of cell death. Methods and achievements in experimental pathology. 1988:13():18-54 [PubMed PMID: 3045494]
Miyamoto O, Auer RN. Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology. 2000 Jan 25:54(2):362-71 [PubMed PMID: 10668697]
Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infection and immunity. 2005 Apr:73(4):1907-16 [PubMed PMID: 15784530]
Caruso RA, Branca G, Fedele F, Irato E, Finocchiaro G, Parisi A, Ieni A. Mechanisms of coagulative necrosis in malignant epithelial tumors (Review). Oncology letters. 2014 Oct:8(4):1397-1402 [PubMed PMID: 25202341]
Level 3 (low-level) evidenceKhalid N, Azimpouran M. Necrosis. StatPearls. 2024 Jan:(): [PubMed PMID: 32491559]
Wu R, Li S, Liu Y, Zhang H, Liu D, Liu Y, Chen W, Wang F. A high proportion of caseous necrosis, abscess, and granulation tissue formation in spinal tuberculosis. Frontiers in microbiology. 2023:14():1230572. doi: 10.3389/fmicb.2023.1230572. Epub 2023 Aug 14 [PubMed PMID: 37645226]
Level 3 (low-level) evidenceManohar M, Verma AK, Venkateshaiah SU, Sanders NL, Mishra A. Pathogenic mechanisms of pancreatitis. World journal of gastrointestinal pharmacology and therapeutics. 2017 Feb 6:8(1):10-25. doi: 10.4292/wjgpt.v8.i1.10. Epub [PubMed PMID: 28217371]
Gapp J, Tariq A, Chandra S. Acute Pancreatitis. StatPearls. 2025 Jan:(): [PubMed PMID: 29494075]
Vasei N, Shishegar A, Ghalkhani F, Darvishi M. Fat necrosis in the Breast: A systematic review of clinical. Lipids in health and disease. 2019 Jun 11:18(1):139. doi: 10.1186/s12944-019-1078-4. Epub 2019 Jun 11 [PubMed PMID: 31185981]
Level 1 (high-level) evidenceGaut JP, Liapis H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clinical kidney journal. 2021 Feb:14(2):526-536. doi: 10.1093/ckj/sfaa142. Epub 2020 Oct 10 [PubMed PMID: 33623675]
Level 2 (mid-level) evidencePasotti M,Prati F,Arbustini E, The pathology of myocardial infarction in the pre- and post-interventional era. Heart (British Cardiac Society). 2006 Nov; [PubMed PMID: 16621872]
Adhami F, Liao G, Morozov YM, Schloemer A, Schmithorst VJ, Lorenz JN, Dunn RS, Vorhees CV, Wills-Karp M, Degen JL, Davis RJ, Mizushima N, Rakic P, Dardzinski BJ, Holland SK, Sharp FR, Kuan CY. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. The American journal of pathology. 2006 Aug:169(2):566-83 [PubMed PMID: 16877357]
Shahid H. Endoscopic management of pancreatic fluid collections. Translational gastroenterology and hepatology. 2019:4():15. doi: 10.21037/tgh.2019.01.09. Epub 2019 Feb 26 [PubMed PMID: 30976718]
Lip GYH, Lane DA, Lenarczyk R, Boriani G, Doehner W, Benjamin LA, Fisher M, Lowe D, Sacco RL, Schnabel R, Watkins C, Ntaios G, Potpara T. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. European heart journal. 2022 Jul 7:43(26):2442-2460. doi: 10.1093/eurheartj/ehac245. Epub [PubMed PMID: 35552401]
Larkins-Ford J, Aldridge BB. Advances in the design of combination therapies for the treatment of tuberculosis. Expert opinion on drug discovery. 2023 Jan:18(1):83-97. doi: 10.1080/17460441.2023.2157811. Epub 2022 Dec 28 [PubMed PMID: 36538813]
Level 3 (low-level) evidenceBhargava A, Mahakalkar C, Kshirsagar S. Understanding Gangrene in the Context of Peripheral Vascular Disease: Prevalence, Etiology, and Considerations for Amputation-Level Determination. Cureus. 2023 Nov:15(11):e49026. doi: 10.7759/cureus.49026. Epub 2023 Nov 18 [PubMed PMID: 38116352]
Level 3 (low-level) evidenceGuo S, Dipietro LA. Factors affecting wound healing. Journal of dental research. 2010 Mar:89(3):219-29. doi: 10.1177/0022034509359125. Epub 2010 Feb 5 [PubMed PMID: 20139336]
Level 3 (low-level) evidenceWijdicks EFM. Liquefactive necrosis of the brain. Intensive care medicine. 2020 Jul:46(7):1466-1467. doi: 10.1007/s00134-019-05856-y. Epub 2019 Nov 18 [PubMed PMID: 31740985]